The Clorox Co. said its normalized net income for the fiscal fourth quarter ended June 30 was $1.40 per share, compared with the S&P Capital IQ consensus estimate of $1.49 per share.
EPS increased 17.6% year over year from $1.19.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $185.0 million, a gain of 17.9% from $156.9 million in the prior-year period.
The normalized profit margin climbed to 11.2% from 9.8% in the year-earlier period.
Total revenue rose on an annual basis to $1.65 billion from $1.60 billion, and total operating expenses totaled $1.35 billion, compared with $1.35 billion in the prior-year period.
Reported net income increased 22.5% from the prior-year period to $201.9 million, or $1.53 per share, from $164.9 million, or $1.25 per share.
For the year, the company's normalized net income totaled $4.96 per share, compared with the S&P Capital IQ consensus normalized EPS estimate of $5.32.
EPS rose 6.5% from $4.66 in the prior year.
Normalized net income was $653.1 million, a gain of 6.4% from $613.8 million in the prior year.
Full-year total revenue grew from the prior-year period to $5.97 billion from $5.76 billion, and total operating expenses grew year over year to $4.86 billion from $4.71 billion.
The company said reported net income increased 8.6% on an annual basis to $703.9 million, or $5.35 per share, in the full year, from $648.0 million, or $4.92 per share.